These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25224346)

  • 1. Evaluation of the efficacy and safety of changes in antiretroviral regimens for HIV-infected patients.
    Tanaka H; Wada T; Takayama Y; Matsumoto K; Atsuda K; Satoh M
    J Pharm Pharm Sci; 2014; 17(3):316-23. PubMed ID: 25224346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [First antiretroviral therapy regimen in HIV-infected patients. Durability and factors associated with therapy changes].
    de la Torre J; Santos J; Perea-Milla E; Pérez I; Moreno F; Palacios R; Santamaría S; Del Arco A; Nuño E; Godoy M; Prada JL; Olalla J; Aguilar J; Martos F;
    Enferm Infecc Microbiol Clin; 2008; 26(7):416-22. PubMed ID: 18842236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
    Stone VE; Jordan J; Tolson J; Miller R; Pilon T
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):808-16. PubMed ID: 15213564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients.
    Cicconi P; Cozzi-Lepri A; Castagna A; Trecarichi EM; Antinori A; Gatti F; Cassola G; Sighinolfi L; Castelli P; d'Arminio Monforte A;
    HIV Med; 2010 Feb; 11(2):104-13. PubMed ID: 19732176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A decade of antiretroviral therapy: a profile of patients with 10 years of highly effective triple therapy].
    Wilson G; Wolff M
    Rev Chilena Infectol; 2012 Jun; 29(3):337-43. PubMed ID: 23096476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of initial highly active anti-retroviral therapy regimen change and its predictors among adult HIV patients at University of Gondar Referral Hospital, Northwest Ethiopia: a retrospective follow up study.
    Anlay DZ; Alemayehu ZA; Dachew BA
    AIDS Res Ther; 2016; 13():10. PubMed ID: 26889204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacovigilance study of adults on highly active antiretroviral therapy, South Africa: 2007 - 2011.
    Dube NM; Summers R; Tint KS; Mayayise G
    Pan Afr Med J; 2012; 11():39. PubMed ID: 22593775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Effectiveness of Highly Active Antiretroviral Therapy in Treatment-Naïve HIV Patients: Preliminary Findings of a Cohort Event Monitoring Study in Belarus.
    Setkina S; Dotsenko M; Bondar S; Charnysh I; Kuchko A; Kaznacheeva A; Kozorez E; Dodaleva A; Rossa N
    Drug Saf; 2015 Apr; 38(4):365-72. PubMed ID: 25808626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV Medicine.
    Mocroft A; Devereux H; Kinloch-de-Loes S; Wilson D; Madge S; Youle M; Tyrer M; Loveday C; Phillips AN; Johnson MA
    AIDS; 2000 Jul; 14(11):1545-52. PubMed ID: 10983641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of antiretroviral HIV/AIDS treatment in a Rio de Janeiro public clinic.
    Carmody ER; Diaz T; Starling P; dos Santos AP; Sacks HS
    Trop Med Int Health; 2003 May; 8(5):378-85. PubMed ID: 12753630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of etravirine-based therapy for treatment-experienced HIV-infected patients.
    Huerta García G; Mata-Marín JA; Domínguez-Hermosillo JC; Chavez-García M; Banda-Lara MI; Nuñez-Rodríguez N; Cruz-Herrera JE; Sandoval-Ramírez JL; Villagómez-Ruiz A; Manjarrez-Tellez B; Gaytan-Martínez JE
    J Infect Dev Ctries; 2016 Jun; 10(6):605-11. PubMed ID: 27367009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients.
    Burgos J; Crespo M; Falcó V; Curran A; Navarro J; Imaz A; Domingo P; Podzamczer D; Mateo MG; Villar S; Van den Eynde E; Ribera E; Pahissa A
    J Antimicrob Chemother; 2012 Oct; 67(10):2479-86. PubMed ID: 22729925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
    Braithwaite RS; Kozal MJ; Chang CC; Roberts MS; Fultz SL; Goetz MB; Gibert C; Rodriguez-Barradas M; Mole L; Justice AC
    AIDS; 2007 Jul; 21(12):1579-89. PubMed ID: 17630553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study.
    Carr A; Chuah J; Hudson J; French M; Hoy J; Law M; Sayer D; Emery S; Cooper DA
    AIDS; 2000 Jun; 14(9):1171-80. PubMed ID: 10894281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.
    Barrios A; Negredo E; Domingo P; Estrada V; Labarga P; Asensi V; Morales D; Santos J; Clotet B; Soriano V;
    Antivir Ther; 2005; 10(7):825-32. PubMed ID: 16312178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.